Blackstone Inc Annexon, Inc. Transaction History

Blackstone Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $594 - $1,802	283 Added 0.03%	910,494 $3.2 Million
Q3 2021 Nov 16, 2021	SELL	$16.35 - $23.4 $29.8 Million - $42.6 Million	-1,820,424 Reduced 66.67%	910,211 $16.9 Million
Q3 2020 Nov 16, 2020	BUY	$17.5 - $30.23 $47.8 Million - $82.5 Million	2,730,635 New	2,730,635 $82.5 Million

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.